Minimum reporting requirements for newly established human tumor-derived cell lines: a pragmatic checklist anchored to ICLAC, Cellosaurus/RRID, Nature Portfolio standards, and UKCCCR guidelines

Tadashi Kondo

Open source

DOI
10.1007/s13577-026-01413-0
Published
2026-07-16
Container
Human Cell
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13577-026-01413-0,
  title = {Minimum reporting requirements for newly established human tumor-derived cell lines: a pragmatic checklist anchored to ICLAC, Cellosaurus/RRID, Nature Portfolio standards, and UKCCCR guidelines},
  author = {Tadashi Kondo},
  year = {2026},
  journal = {Human Cell},
  doi = {10.1007/s13577-026-01413-0},
  url = {https://doi.org/10.1007/s13577-026-01413-0}
}

RIS

TY  - JOUR
TI  - Minimum reporting requirements for newly established human tumor-derived cell lines: a pragmatic checklist anchored to ICLAC, Cellosaurus/RRID, Nature Portfolio standards, and UKCCCR guidelines
AU  - Tadashi Kondo
PY  - 2026
JO  - Human Cell
DO  - 10.1007/s13577-026-01413-0
UR  - https://doi.org/10.1007/s13577-026-01413-0
ER  - 

APA

Kondo, T. (2026). Minimum reporting requirements for newly established human tumor-derived cell lines: a pragmatic checklist anchored to ICLAC, Cellosaurus/RRID, Nature Portfolio standards, and UKCCCR guidelines. Human Cell. https://doi.org/10.1007/s13577-026-01413-0

Source records